These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7900073)

  • 1. Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Dunselman PH; Mulder BJ; Michels HR; Buser PT; van Gilst WH; Lie KI
    Thromb Haemost; 1994 Nov; 72(5):676-81. PubMed ID: 7900073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin in aortocoronary bypass surgery: increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study.
    van der Meer J; Hillege HL; Ascoop CA; Dunselman PH; Mulder BJ; van Ommen GV; Pfisterer M; van Gilst WH; Lie KI
    Thromb Haemost; 1996 Jan; 75(1):1-3. PubMed ID: 8713770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: a prospective, randomized study.
    Gohlke H; Gohlke-Bärwolf C; Stürzenhofecker P; Görnandt L; Ritter B; Reichelt M; Buchwalsky R; Schmuziger M; Roskamm H
    Circulation; 1981 Aug; 64(2 Pt 2):II22-7. PubMed ID: 6972824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
    Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
    Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of vein graft use on postoperative 1-year results after off-pump coronary artery bypass surgery.
    Cho KR; Jeong DS; Kim KB
    Eur J Cardiothorac Surg; 2007 Nov; 32(5):718-23. PubMed ID: 17822913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women. CABADAS. Research Group of the Interuniversity Cardiology Institute of The Netherlands. Coronary Artery Bypass graft occlusion by Aspirin, Dipyridamole and Acenocoumarol/phenoprocoumon Study.
    Tan ES; van der Meer J; Jan de Kam P; Dunselman PH; Mulder BJ; Ascoop CA; Pfisterer M; Lie KI
    J Am Coll Cardiol; 1999 Nov; 34(6):1760-8. PubMed ID: 10577567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of anticoagulant treatment after aortocoronary bypass].
    Lalau JD; Lesbre JP
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):441-7. PubMed ID: 6391358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery.
    Muneretto C; Bisleri G; Negri A; Manfredi J; Metra M; Nodari S; Culot L; Dei Cas L
    Circulation; 2003 Sep; 108 Suppl 1():II29-33. PubMed ID: 12970204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
    Chesebro JH; Fuster V
    Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of patient self-managed versus physician-managed oral anticoagulation.
    Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A
    Can J Cardiol; 2004 Sep; 20(11):1117-23. PubMed ID: 15457308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation.
    Muneretto C; Bisleri G; Negri A; Manfredi J; Carone E; Morgan JA; Metra M; Dei Cas L
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):179-84. PubMed ID: 14752429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.